Clinical safety of insulin detemir in patients with Type 2 diabetes in the Gulf countries: The multicenter, noninterventional, open-label LevSafe study

Clinical safety of insulin detemir in patients with Type 2 diabetes in the Gulf countries: The multicenter, noninterventional, open-label LevSafe study

Aim: To evaluate the safety profile of insulin detemir (IDet) in people with Type 2 diabetes mellitus (T2DM) in the Gulf countries in the 32-week, noninterventional LevSafe study. Methods: People with T2DM whose physicians had opted to start IDet therapy were included in the study. Safety parameters...

Full description

Bibliographic Details
Main Authors: Abdel Rahman El Shiekh, Hesham A Farrag, Tarek Ashour, Khalid Zaki Alshali, Waleed AbdelFattah
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Indian Journal of Endocrinology and Metabolism
Subjects:
Gulf
insulin detemir
LevSafe
noninterventional study
Type 2 diabetes
Online Access:http://www.ijem.in/article.asp?issn=2230-8210;year=2016;volume=20;issue=4;spage=443;epage=450;aulast=El

Similar Items

Similar Items